Roivant Sciences

Roivant Sciences

Biotechnology, 50 Broadway Fl 7, , , SW1H 0BD, New York, United States, 201-500 Employees

roivant.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 21********

Who is ROIVANT SCIENCES

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants nimble, entrepreneurial biotech and healthcare technol...

Read More

map
  • 50 Broadway Fl 7, New York, New York, SW1H 0BD, United States Headquarters: 50 Broadway Fl 7, New York, New York, SW1H 0BD, United States
  • 2014 Date Founded: 2014
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ROIVANT SCIENCES

Roivant Sciences Org Chart and Mapping

Employees

Yujie Wu

Director of Free Energy Methods

CPSM Kris Ungvarsky

Head of Sourcing & Finance Operations

Qingxian Lin

Director - Chemistry, Manufacturing, and Control (Cmc) Operations

Keisuke Kuida

Executive Medical Director

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Roivant Sciences

Answer: Roivant Sciences's headquarters are located at 50 Broadway Fl 7, , , SW1H 0BD, New York, United States

Answer: Roivant Sciences's phone number is 21********

Answer: Roivant Sciences's official website is https://roivant.com

Answer: Roivant Sciences's revenue is $10 Million to $25 Million

Answer: Roivant Sciences's SIC: 2834

Answer: Roivant Sciences's NAICS: 325412

Answer: Roivant Sciences has 201-500 employees

Answer: Roivant Sciences is in Biotechnology

Answer: Roivant Sciences contact info: Phone number: 21******** Website: https://roivant.com

Answer: Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinsons disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access